REG - PureTech Health PLC - Transaction in Own Shares
30/01/2024 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240130:nRSd2808Ba&default-theme=true
RNS Number : 2808B PureTech Health PLC 30 January 2024
30 January 2024
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has purchased the
following number of its ordinary shares of one pence each through Jefferies
International Limited ("Jefferies"), as part of its Share Buyback Programme,
details of which were announced on 9 May 2022.
Date of purchase: 29 January 2024
Number of ordinary shares purchased: 54,835
Highest price paid per share: 198.60p
Lowest price paid per share: 194.00p
Volume weighted average price paid per share: 196.22p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have 19,057,405 ordinary
shares in treasury and has 270,410,754 ordinary shares in issue (excluding
treasury shares). The total number of voting rights in the Company is
therefore 270,410,754 which may be used by shareholders in their calculations
to determine if they are required to notify their interest in, or a change to
their interest in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as
incorporated into UK domestic law by the European Union (Withdrawal) Act 2018)
(the Market Abuse Regulation), detailed information about the individual
purchases is available below.
About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to giving life
to new classes of medicine to change the lives of patients with devastating
diseases. The Company has created a broad and deep pipeline through its
experienced research and development team and its extensive network of
scientists, clinicians and industry leaders that is being advanced both
internally and through its Founded Entities. PureTech's R&D engine has
resulted in the development of 27 therapeutics and therapeutic candidates,
including two (Plenity® and EndeavorRx®) that have received both U.S.
FDA clearance and European marketing authorization and a third (KarXT) that
has been filed for FDA approval. A number of these programs are being advanced
by PureTech or its Founded Entities in various indications and stages of
clinical development, including registration enabling studies. All of the
underlying programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and then
advanced by the PureTech team through key validation points.
For more information, visit www.puretechhealth.com
(http://www.puretechhealth.com/) or connect with us on X, formerly known as
Twitter, @puretechh.
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
Individual Transactions
Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
29/01/2024 08:10:59 247 198.6 AQXE 00387561240TRLO0.1.1
29/01/2024 08:10:59 1539 198.6 XLON 00387561241TRLO0.1.1
29/01/2024 08:11:00 200 196.2 BATE 00387561243TRLO0.1.1
29/01/2024 09:24:29 247 197 AQXE 00387574739TRLO0.1.1
29/01/2024 09:24:29 474 197 CHIX 00387574741TRLO0.1.1
29/01/2024 09:24:29 513 197 CHIX 00387574740TRLO0.1.1
29/01/2024 09:24:29 513 197 BATE 00387574742TRLO0.1.1
29/01/2024 09:24:29 39 197 CHIX 00387574743TRLO0.1.1
29/01/2024 09:24:29 1333 197 XLON 00387574744TRLO0.1.1
29/01/2024 09:24:29 206 197 XLON 00387574745TRLO0.1.1
29/01/2024 09:24:29 1041 197 XLON 00387574746TRLO0.1.1
29/01/2024 09:24:30 136 196 TRQX 00387574765TRLO0.1.1
29/01/2024 09:24:34 490 196.4 XLON 00387574766TRLO0.1.1
29/01/2024 09:24:34 387 196.4 XLON 00387574767TRLO0.1.1
29/01/2024 09:24:34 938 196.6 XLON 00387574768TRLO0.1.1
29/01/2024 09:24:34 380 196.6 XLON 00387574769TRLO0.1.1
29/01/2024 09:25:25 37 196.4 XLON 00387574876TRLO0.1.1
29/01/2024 09:25:25 281 196.4 XLON 00387574877TRLO0.1.1
29/01/2024 09:25:25 1063 196.6 XLON 00387574878TRLO0.1.1
29/01/2024 09:25:49 92 196.4 XLON 00387574912TRLO0.1.1
29/01/2024 09:58:13 56 196.4 XLON 00387578519TRLO0.1.1
29/01/2024 09:58:36 29 196.4 XLON 00387578541TRLO0.1.1
29/01/2024 09:58:40 13 196.4 CHIX 00387578542TRLO0.1.1
29/01/2024 09:59:04 82 196.4 CHIX 00387578590TRLO0.1.1
29/01/2024 10:31:53 490 197 XLON 00387582271TRLO0.1.1
29/01/2024 10:31:57 1521 196.2 XLON 00387582322TRLO0.1.1
29/01/2024 10:56:58 513 196.2 BATE 00387585203TRLO0.1.1
29/01/2024 10:56:58 513 196.2 BATE 00387585204TRLO0.1.1
29/01/2024 10:56:58 513 196.2 CHIX 00387585206TRLO0.1.1
29/01/2024 10:56:58 513 196.2 CHIX 00387585205TRLO0.1.1
29/01/2024 10:56:58 33 196.2 AQXE 00387585208TRLO0.1.1
29/01/2024 10:56:58 214 196.2 AQXE 00387585207TRLO0.1.1
29/01/2024 10:56:58 75 196.2 AQXE 00387585209TRLO0.1.1
29/01/2024 10:56:58 136 196.2 TRQX 00387585211TRLO0.1.1
29/01/2024 10:56:58 500 196.2 XLON 00387585210TRLO0.1.1
29/01/2024 10:56:58 31 196.2 XLON 00387585212TRLO0.1.1
29/01/2024 10:56:58 3168 196.2 XLON 00387585213TRLO0.1.1
29/01/2024 10:56:58 500 196.2 XLON 00387585214TRLO0.1.1
29/01/2024 10:56:58 311 196.2 XLON 00387585215TRLO0.1.1
29/01/2024 10:56:58 500 196.2 XLON 00387585216TRLO0.1.1
29/01/2024 10:56:58 523 196.2 XLON 00387585218TRLO0.1.1
29/01/2024 10:56:58 1000 196.2 XLON 00387585217TRLO0.1.1
29/01/2024 10:59:09 440 195 XLON 00387585392TRLO0.1.1
29/01/2024 10:59:09 73 195 XLON 00387585393TRLO0.1.1
29/01/2024 11:00:56 418 194 CHIX 00387585618TRLO0.1.1
29/01/2024 11:00:56 1634 194 XLON 00387585619TRLO0.1.1
29/01/2024 11:00:56 136 194 TRQX 00387585621TRLO0.1.1
29/01/2024 11:00:56 418 194 XLON 00387585620TRLO0.1.1
29/01/2024 11:48:46 224 195 AQXE 00387592000TRLO0.1.1
29/01/2024 11:48:46 36 194.6 TRQX 00387592002TRLO0.1.1
29/01/2024 11:48:46 1539 195 XLON 00387592001TRLO0.1.1
29/01/2024 11:48:46 136 194.6 TRQX 00387592003TRLO0.1.1
29/01/2024 11:48:52 1320 194.8 XLON 00387592010TRLO0.1.1
29/01/2024 11:48:52 219 195 XLON 00387592011TRLO0.1.1
29/01/2024 11:55:07 18 194.8 BATE 00387592725TRLO0.1.1
29/01/2024 11:55:07 375 194.8 BATE 00387592726TRLO0.1.1
29/01/2024 11:56:42 9 194.8 XLON 00387592870TRLO0.1.1
29/01/2024 11:56:42 81 195 XLON 00387592871TRLO0.1.1
29/01/2024 11:57:31 7 194.8 XLON 00387592946TRLO0.1.1
29/01/2024 11:57:31 63 195 XLON 00387592947TRLO0.1.1
29/01/2024 12:08:53 1379 195 XLON 00387594321TRLO0.1.1
29/01/2024 14:27:26 200 195.8 XLON 00387624506TRLO0.1.1
29/01/2024 14:30:59 66 196.6 XLON 00387627370TRLO0.1.1
29/01/2024 14:31:47 20 196.6 XLON 00387628387TRLO0.1.1
29/01/2024 14:52:16 247 196.2 AQXE 00387645182TRLO0.1.1
29/01/2024 14:52:16 48 196.2 CHIX 00387645183TRLO0.1.1
29/01/2024 14:52:16 364 196.2 CHIX 00387645184TRLO0.1.1
29/01/2024 14:52:16 490 196.6 XLON 00387645207TRLO0.1.1
29/01/2024 14:52:16 1111 196.6 XLON 00387645206TRLO0.1.1
29/01/2024 14:52:16 357 196.6 XLON 00387645208TRLO0.1.1
29/01/2024 14:52:16 201 196.6 XLON 00387645209TRLO0.1.1
29/01/2024 14:52:16 1792 196.6 XLON 00387645210TRLO0.1.1
29/01/2024 14:54:43 1918 196.2 XLON 00387647521TRLO0.1.1
29/01/2024 15:05:14 216 196 AQXE 00387653511TRLO0.1.1
29/01/2024 15:05:14 31 196 AQXE 00387653512TRLO0.1.1
29/01/2024 15:05:14 247 196 AQXE 00387653513TRLO0.1.1
29/01/2024 15:05:14 94 195.8 BATE 00387653515TRLO0.1.1
29/01/2024 15:05:14 55 195.8 BATE 00387653514TRLO0.1.1
29/01/2024 15:05:14 31 195.8 BATE 00387653516TRLO0.1.1
29/01/2024 15:05:14 257 195.8 XLON 00387653517TRLO0.1.1
29/01/2024 15:05:14 80 195.8 XLON 00387653518TRLO0.1.1
29/01/2024 15:05:14 119 195.8 XLON 00387653520TRLO0.1.1
29/01/2024 15:05:14 57 195.8 XLON 00387653519TRLO0.1.1
29/01/2024 15:05:47 34 196.4 CHIX 00387653764TRLO0.1.1
29/01/2024 15:48:07 500 196.4 CHIX 00387674116TRLO0.1.1
29/01/2024 15:48:07 13 196.4 CHIX 00387674117TRLO0.1.1
29/01/2024 16:03:43 247 196 AQXE 00387682734TRLO0.1.1
29/01/2024 16:03:43 293 195.8 BATE 00387682735TRLO0.1.1
29/01/2024 16:03:43 40 195.8 BATE 00387682736TRLO0.1.1
29/01/2024 16:03:43 79 195.8 BATE 00387682737TRLO0.1.1
29/01/2024 16:03:43 434 195.8 BATE 00387682738TRLO0.1.1
29/01/2024 16:03:43 3078 196 XLON 00387682739TRLO0.1.1
29/01/2024 16:03:43 827 196.4 CHIX 00387682741TRLO0.1.1
29/01/2024 16:03:43 431 196.4 CHIX 00387682742TRLO0.1.1
29/01/2024 16:04:37 55 196.4 CHIX 00387683185TRLO0.1.1
29/01/2024 16:04:52 442 196.4 CHIX 00387683367TRLO0.1.1
29/01/2024 16:10:33 253 196.4 XLON 00387686336TRLO0.1.1
29/01/2024 16:10:33 135 196.4 XLON 00387686338TRLO0.1.1
29/01/2024 16:10:38 226 196.4 XLON 00387686431TRLO0.1.1
29/01/2024 16:14:38 290 196.4 XLON 00387689848TRLO0.1.1
29/01/2024 16:14:38 222 196.4 XLON 00387689849TRLO0.1.1
29/01/2024 16:15:41 144 196 AQXE 00387690469TRLO0.1.1
29/01/2024 16:25:33 1801 196.6 XLON 00387696574TRLO0.1.1
29/01/2024 16:25:33 117 196.6 XLON 00387696575TRLO0.1.1
29/01/2024 16:25:33 43 196.6 XLON 00387696577TRLO0.1.1
29/01/2024 16:25:33 411 196.6 XLON 00387696576TRLO0.1.1
29/01/2024 16:28:14 58 196.6 AQXE 00387698138TRLO0.1.1
29/01/2024 16:28:40 15 196.6 XLON 00387698359TRLO0.1.1
29/01/2024 16:29:27 144 196.6 AQXE 00387698727TRLO0.1.1
29/01/2024 16:29:39 138 196.6 XLON 00387699068TRLO0.1.1
29/01/2024 16:29:39 75 196.6 XLON 00387699069TRLO0.1.1
29/01/2024 16:29:39 116 196.6 XLON 00387699070TRLO0.1.1
29/01/2024 16:29:39 2708 196.6 XLON 00387699072TRLO0.1.1
29/01/2024 16:29:39 288 196.6 XLON 00387699074TRLO0.1.1
29/01/2024 16:29:39 93 196.6 XLON 00387699075TRLO0.1.1
29/01/2024 16:29:39 2656 196.6 XLON 00387699076TRLO0.1.1
29/01/2024 16:29:46 513 197 XLON 00387699247TRLO0.1.1
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSFLFITLEIAFISRecent news on Puretech Health
See all newsREG - PureTech Health PLC - Total Voting Rights
AnnouncementREG - PureTech Health PLC - Final Results
AnnouncementREG - PureTech Health PLC - Notice of Results
AnnouncementRCS - PureTech Health PLC - PRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
AnnouncementRCS - PureTech Health PLC - FDA Grants PRTC's LYT-200 Fast Track Designation
Announcement